SaaS ARR Scale and Mix
SaaS ARR was $638.5M in Q4, representing 86% of total ARR; total ARR was $745.4M, up 16% year-over-year.
Strong SaaS Growth (Excluding Conversions)
SaaS ARR increased 32% year-over-year in Q4 when excluding the impact of conversions; company is focusing on reporting SaaS ARR excluding conversions as a primary KPI.
Record Conversions in Q4
Approximately $65M of ARR conversions occurred in Q4 (about one-third of remaining non-SaaS ARR), driven by the end-of-life announcement for the self-hosted product.
Healthy Customer Metrics
Ended 2025 with ~6,400 subscription customers (up 14% YoY) and SaaS dollar-based net retention of 110%; renewal rate remained over 90% overall.
Revenue and Cash Generation
Q4 total revenues were $173.4M (up 9% YoY); full-year 2025 total revenues $623.5M (up 13% YoY); generated $147.4M cash from operations for the year and $131.9M free cash flow in 2025 (up from $108.5M).
Strong Balance Sheet and Share Repurchase
As of Dec 31, 2025, cash, equivalents, short-term deposits and marketable securities were $1.1B; repurchased 448,439 shares for $15M in Q4.
Strategic M&A to Address AI Risk
Announced acquisition of Altu (AI security) to add end-to-end visibility and guardrails for AI tools, reinforcing a data-first strategy and extending the platform to secure AI systems.
Notable Customer Wins and Product Momentum
Several large healthcare customer wins cited: one customer saw >900,000 exposed PII records uncovered; another hospital system found >500k HIPAA/PII instances — both converted to Varonis SaaS and MDDR; Interceptor, CoPilot and cloud DSPM momentum highlighted.
Forward Guidance for SaaS and Revenue
Full-year 2026 guidance includes total SaaS ARR $805M–$840M (growth 26%–32%) and SaaS ARR growth excluding conversions in the company’s stated guidance range (management reiterated an 18%–20% organic SaaS ARR growth target during commentary).